September 26, 2011
Astellas Pharma announced on September 15 that the European Commission has granted marketing authorization for the antibiotic Vibativ (telavancin HCl). The authorization is granted for the treatment of adults with nosocomial pneumonia, including ventilator-associated pneumonia, known or suspected to be...read more